STAAR Surgical Names Deborah Andrews as Chief Financial Officer, Forms Capital Stewardship Committee of the Board of Directors
Published on June 26, 2025
LAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a manufacturer of the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, announced that Deborah Andrews has been appointed chief financial officer (CFO), effective June 25, 2025. Andrews has served as STAAR Surgical’s interim CFO since March 2025, and she previously served as the company’s CFO from 2007-2013 and 2017-2020. “Deborah has blended seamlessly with the leadership team, and we quickly realized that her deep knowledge of STAAR and her skills, abilities and approach made her the perfect choice to be STAAR’s next CFO,” said Stephen Farrell, the company’s CEO and board member.